A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : AZT

Search Conditions:
Search Keyword : AZT
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: AZT
Appearance Frequency: 1598 time(s)
Long forms: 208

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
3'-azido-3'-deoxythymidine
(1106 times)
Biochemistry
(175 times)
HIV (144 times)
HIV-1 (113 times)
RT (82 times)
1986 Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
aztreonam
(138 times)
Anti-Bacterial Agents
(99 times)
CAZ (18 times)
AMK (13 times)
IPM (12 times)
1985 [Fundamental and clinical studies on aztreonam in obstetrics and gynecology].
azithromycin
(34 times)
Pharmacology
(7 times)
CRO (2 times)
FOS (2 times)
HCQ (2 times)
1998 [Inhibitory activity of azithromycin on biofilm synthesis and synergism between azithromycin and fleroxacin on Pseudomonas aeruginosa in biofilms].
antiretroviral drug zidovudine
(20 times)
Chemistry
(5 times)
AIDS (1 time)
ATL (1 time)
COSATU (1 time)
1991 Use of a human liver microsome bank in drug glucuronidation studies.
activity of zidovudine
(17 times)
Virology
(3 times)
HIV (4 times)
M/M (3 times)
ADR (2 times)
1990 Effect of zidovudine and granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus replication in alveolar macrophages.
agent zidovudine
(16 times)
Pharmacology
(4 times)
ATL (2 times)
HIV (2 times)
IFN (2 times)
1988 Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography.
administration of zidovudine
(11 times)
Neurology
(2 times)
AIDS (2 times)
HIV (2 times)
ANM (1 time)
1989 [HIV and the central nervous system].
azathioprine
(10 times)
Gastroenterology
(4 times)
Ig (2 times)
5-ASA (1 time)
aCL (1 time)
2001 Autoimmune liver disease in children.
Antiretroviral therapy, as zidovudine
(8 times)
Medicine
(2 times)
AIDS (2 times)
ddI (2 times)
HAART (2 times)
1989 Virology, immunology, and natural history of HIV infection.
10  3'-deoxy-3'-azidothymidine
(7 times)
Virology
(2 times)
ddC (2 times)
HIV (2 times)
NDP (2 times)
1992 Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.
11  ability to ameliorate 3'azido-3'deoxythymidine
(3 times)
Hematology
(2 times)
BFU-E (2 times)
SCF (2 times)
HIV (1 time)
1994 Amelioration of azidothymidine-induced erythroid toxicity by hemin and stem cell factor in immune-suppressed mice.
12  adherence to zidovudine
(3 times)
Substance-Related Disorders
(2 times)
MCV (2 times)
IDUs (1 time)
MEMS (1 time)
1995 Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care.
13  administered zidovudine
(3 times)
Disease
(1 time)
MDR (1 time)
NF (1 time)
NRTIs (1 time)
1990 Existence of a flip-flop kinetic model for zidovudine (AZT) after oral administration.
14  Although zidovudine
(3 times)
Hematology
(1 time)
ATLL (1 time)
HTLV-1 (1 time)
IFN (1 time)
2004 Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
15  ART with zidovudine
(3 times)
Acquired Immunodeficiency Syndrome
(1 time)
AIDS (1 time)
ART (1 time)
ATVr (1 time)
1990 Approaches to interferon combination therapy in the treatment of AIDS.
16  assay was developed for the simultaneous determination of zidovudine
(3 times)
Chromatography
(1 time)
HPLC (2 times)
IS (2 times)
2000 Simultaneous determination of zidovudine and its monophosphate in mouse plasma and peripheral red blood cells by high-performance liquid chromatography.
17  assess the effects of zidovudine
(3 times)
Health Services Research
(2 times)
ddI (2 times)
ROS (1 time)
2000 Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
18  azidothymidine, zidovudine, ZDV
(3 times)
Neurology
(2 times)
PND (3 times)
AMP (1 time)
ASR (1 time)
1999 Neurobehavioral effects of perinatal AZT exposure in Sprague-Dawley adult rats.
19  3'-azido-3'-deoxythymidine, zidovudine
(2 times)
Metabolism
(1 time)
PH (1 time)
2012 Metabolism of deoxypyrimidines and deoxypyrimidine antiviral analogs in isolated brain mitochondria.
20  access to zidovudine
(2 times)
Internal Medicine
(1 time)
--- 1990 All AIDS patients should have access to zidovudine (AZT)
21  adjunct to zidovudine
(2 times)
Allergy and Immunology
(1 time)
--- 1995 Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS.
22  after the initiation of azidothymidine
(2 times)
Internal Medicine
(1 time)
AIDS (1 time)
RT (1 time)
1987 Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS).
23  after treatment with azidothymidine
(2 times)
Acquired Immunodeficiency Syndrome
(1 time)
IVIG (1 time)
1991 Central nervous system involvement of children with HIV infection.
24  AIDS patients with zidovudine
(2 times)
Nursing
(1 time)
ddI (1 time)
NNRTI (1 time)
NRTI (1 time)
1991 AIDS patients on zidovudine (AZT) live three times longer.
25  AIDS treated with zidovudine
(2 times)
Pediatrics
(1 time)
--- 1992 [Long-term follow-up study of 35 children with ADS treated with zidovudine (AZT)].
26  alone or with zidovudine
(2 times)
Veterinary Medicine
(1 time)
FeLV (2 times)
IFN alpha-2b (1 time)
IFNalpha2b (1 time)
1993 Reversal of feline leukemia virus infection by adoptive transfer of lectin/interleukin-2-activated lymphocytes, interferon-alpha, and zidovudine.
27  amounts of zidovudine
(2 times)
Antineoplastic Agents
(1 time)
HIV (1 time)
IVDUs (1 time)
RT (1 time)
1990 Therapy may explain recent deficits in AIDS incidence.
28  anti-HIV drugs such as zidovudine
(2 times)
Anti-Bacterial Agents
(1 time)
AZT-M (1 time)
ddI (1 time)
RES (1 time)
1997 Chloropeptins, new anti-HIV antibiotics inhibiting gp120-CD4 binding from Streptomyces sp. I. Taxonomy, fermentation, isolation, and physico-chemical properties and biological activities.
29  antiretroviral regimens containing zidovudine
(2 times)
Drug Therapy
(1 time)
COX (1 time)
COX-4 (1 time)
TAMs (1 time)
2009 Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months.
30  antiretroviral therapy using the combination of zidovudine
(2 times)
Hematology
(1 time)
ATL (1 time)
ATLL (1 time)
HSCT (1 time)
2005 In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.
31  antiviral duplex drug linking Zidovudine
(2 times)
Biochemistry
(1 time)
ACV (1 time)
AZT-lipid-PFA (1 time)
GCV (1 time)
2009 Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
32  assess the effects of immediate versus deferred zidovudine
(2 times)
Health Services Research
(2 times)
CI (2 times)
RR (2 times)
2000 Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
33  assessed the effects of 3'-azido-3'-deoxythymidine
(2 times)
Communicable Diseases
(1 time)
3TC (1 time)
ddI (1 time)
EBV (1 time)
1989 Synergistic inhibition of Epstein-Barr virus: transformation of B lymphocytes by alpha and gamma interferon and by 3'-azido-3'-deoxythymidine.
34  azilsartan
(2 times)
Medicine
(2 times)
MPO (2 times)
5-FU (1 time)
COX-2 (1 time)
2014 Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model.
35  cent-azido-3 cent-deoxythymidine
(2 times)
Biology
(1 time)
RT (1 time)
2009 Electronic structure of the azide group in 3 cent-azido-3 cent-deoxythymidine (AZT) compared to small azide compounds.
36  1-(3-azido-2,3-dideoxy-beta-D-erythro-pentofuranosyl)thymine
(1 time)
Biochemistry
(1 time)
--- 1991 Synthesis of 1-(3-azido-2,3-dideoxy-beta-D-allofuranosyl)thymine, 1-(2,3-dideoxy-beta-D-allofuranosyl)thymine, and 1-(2,3-dideoxy-beta-D-erythro-hex-2-enofuranosyl)thymine.
37  2,3-dipalmitoyl-sn-glycerol-1-phospho-5'-azidothymidine
(1 time)
Biochemistry
(1 time)
--- 1992 Equal inhibition of HIV replication by stereoisomers of phosphatidyl-azidothymidine. Lack of stereospecificity of lysosomal phospholipase A1.
38  3'-azido-dThd
(1 time)
Pharmacology
(1 time)
dCyd (1 time)
dNK (1 time)
dThd (1 time)
2012 Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications.
39  3'-azidothymidine-3'-deoxythymidine
(1 time)
Biochemistry
(1 time)
AZTTP (1 time)
dThd (1 time)
rIFN-alpha 2a (1 time)
1997 Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells.
40  5,5'-azotetrazolate
(1 time)
Chemistry
(1 time)
--- 2011 Syntheses, structures and multi-photoluminescence images with confocal microscopy for three 5,5'-azotetrazolate (AZT) based Zn(II) and Ni(II) complexes.
41  5-bromo-6-methoxy-3'-azido-3'-deoxythymidine
(1 time)
Reproductive Medicine
(1 time)
HIV (1 time)
SIA (1 time)
1998 Aryl phosphate derivatives of bromo-methoxy-azidothymidine are dual-function spermicides with potent anti-human immunodeficiency virus.
42  ability to drive azidothymidine
(1 time)
Molecular Biology
(1 time)
SGTC (1 time)
2015 Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis.
43  ability to phosphorylate zidovudine
(1 time)
Biotechnology
(1 time)
HSV (1 time)
TK (1 time)
1999 Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling.
44  able to carry zidovudine
(1 time)
Biotechnology
(1 time)
--- 1993 Mab labelled liposomes as selective vehicles for drugs in H.I.V. infected cells.
45  Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine
(1 time)
Laboratory Techniques and Procedures
(1 time)
--- 1991 Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model.
46  Acceptance of zidovudine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
--- 1995 Acceptance of zidovudine (AZT) in early HIV disease: the role of health beliefs.
47  acceptor molecule have been proposed as mechanisms of zidovudine
(1 time)
Biochemistry
(1 time)
PPi (1 time)
RT (1 time)
2001 Tenofovir (PMPA) is less susceptible to pyrophosphorolysis and nucleotide-dependent chain-terminator removal than zidovudine or stavudine.
48  accessibility of zidovudine
(1 time)
Perinatology
(1 time)
--- 2007 AZT Availability in Illinois birthing hospitals: is the perinatal HIV prevention safety net in place?
49  account the increasing impact of new therapies such as zidovudine
(1 time)
Biology
(1 time)
--- 1992 A modeled time-varying density function for the incubation period of AIDS.
50  accurate quantification of zidovudine
(1 time)
Chemistry Techniques, Analytical
(1 time)
RP-HPLC (1 time)
2011 Development and validation of a RP-HPLC method for the determination of zidovudine and its related substances in sustained-release tablets.
51  acetaminophen to HIV-positive patients receiving zidovudine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
--- 1990 The effect of acetaminophen on zidovudine metabolism in HIV-infected patients.
52  acetazolamide
(1 time)
Neurology
(1 time)
CPAP (1 time)
OSA (1 time)
RM-ANOVA (1 time)
2018 Acetazolamide Reduces Blood Pressure and Sleep-Disordered Breathing in Patients With Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial.
53  actinomycin D and cycloheximide, but not with zidovudine
(1 time)
Virology
(1 time)
LDV (1 time)
MuLV (1 time)
1993 Replication of lactate dehydrogenase-elevating virus in various species cell lines infected with dual-, ampho- and xenotropic murine leukaemia viruses in vitro.
54  activities than zidovudine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
CPEs (1 time)
1995 In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol.
55  activity and cytotoxicity of novel zidovudine
(1 time)
Anti-Bacterial Agents
(1 time)
--- 2002 Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation to their chemical structure.
56  activity and hemopoietic toxicity of zidovudine
(1 time)
Anti-Bacterial Agents
(1 time)
HIV (1 time)
1991 Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells.
57  activity and resistance of zidovudine
(1 time)
Communicable Diseases
(1 time)
IS (1 time)
MIC (1 time)
2011 Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains.
58  activity increase zidovudine
(1 time)
Virology
(1 time)
NNRTI (1 time)
RNHI (1 time)
2011 The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC.
59  activity of the NRTI zidovudine
(1 time)
Chemistry
(1 time)
ABC (1 time)
NRTIs (1 time)
2005 The role of breast cancer resistance protein (BCRP/ABCG2) in cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.
60  activity, namely, dermatan sulphate, heparin, dextran sulphate, pentosan polysulphate, zidovudine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
MW (1 time)
1989 In vitro anti-HIV-1 activity of chondroitin polysulphate.
61  acute and chronic zidovudine
(1 time)
Allergy and Immunology
(1 time)
NK (1 time)
PMNs (1 time)
1992 Immunological consequences of zidovudine treatment in control and morphine or methadone treated mice.
62  Acute toxic effects of 3'-azido-3'-deoxythymidine
(1 time)
Hematology
(1 time)
BFU-E (1 time)
CFU-E (1 time)
CFU-GM (1 time)
1994 Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
63  adipose tissue mitochondria in 3'-azido-3'-deoxythymidine
(1 time)
Biochemistry
(1 time)
mtDNA (1 time)
NRTIs (1 time)
2005 Site specific alterations of adipose tissue mitochondria in 3'-azido-3'-deoxythymidine (AZT)-treated rats: an early stage in lipodystrophy?
64  administered nevirapine either as monotherapy or in combination with zidovudine
(1 time)
Virology
(1 time)
HIV-1 (1 time)
RT (1 time)
1994 Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
65  administered the combined regimen of anti-retroviral drug zidovudine
(1 time)
Environmental Health
(1 time)
SBN (1 time)
2016 Zidovudine and isoniazid induced liver toxicity and oxidative stress: Evaluation of mitigating properties of silibinin.
66  administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine
(1 time)
Allergy and Immunology
(1 time)
GM-CSF (1 time)
IL-3 (1 time)
1995 Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
67  administered together with 3'-azido-3'-deoxythymidine
(1 time)
Science
(1 time)
--- 1991 Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine.
68  administration of dose-escalation zidovudine
(1 time)
Allergy and Immunology
(1 time)
GM-CSF (1 time)
IL-3 (1 time)
1995 Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
69  adult Sprague-Dawley rats were subjected to zidovudine
(1 time)
Neoplasms
(1 time)
NRTIs (1 time)
2018 Nucleoside reverse transcriptase inhibitor-induced rat oocyte dysfunction and low fertility mediated by autophagy.
70  Africa, an intensified regimen for the prevention-of-mother-to-child-transmission-of-HIV consisting of zidovudine
(1 time)
Virology
(1 time)
NNRTI (1 time)
NVP (1 time)
SD (1 time)
2008 Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
71  after 6-8 weeks of zidovudine
(1 time)
Nuclear Medicine
(1 time)
CT (1 time)
HIV (1 time)
MRI (1 time)
1991 Single-photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report.
72  after combination therapy with zidovudine
(1 time)
Hematology
(1 time)
ATLL (1 time)
GEPs (1 time)
IFN-alpha (1 time)
2010 Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha.
73  after commencing treatment with zidovudine
(1 time)
Allergy and Immunology
(1 time)
BAL (1 time)
ddI (1 time)
1993 Antiretroviral treatment reverses HIV-induced reduction in the expression of surface antigens on alveolar macrophages in AIDS patients.
74  after prolonged zidovudine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
--- 1998 The Western Australian HIV Cohort Study, Perth, Australia.
75  after starting zidovudine
(1 time)
Internal Medicine
(1 time)
--- 1991 Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
76  after the commencement of therapy with zidovudine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
--- 1991 Population dynamics of HIV within an individual after treatment with zidovudine.
77  after the start of zidovudine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
aa (1 time)
RT (1 time)
WT (1 time)
2001 Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.
78  after transplacental exposure to 3'-azido-3'-deoxythymidine
(1 time)
Neoplasms
(1 time)
8-oxodG (1 time)
ROS (1 time)
2000 Oxidative DNA damage in fetal tissues after transplacental exposure to 3'-azido-3'-deoxythymidine (AZT).
79  agents induced a remarkable decrease in HIV susceptibility to zidovudine
(1 time)
Virology
(1 time)
AZTTP (1 time)
HIV (1 time)
2005 Effect of cell cycle arrest on the activity of nucleoside analogues against human immunodeficiency virus type 1.
80  agents nor systematic Zidovudine
(1 time)
Urology
(1 time)
--- 1992 HIV infection and rape.
81  agents that induce mitochondrial dysfunction, such as zidovudine
(1 time)
Biochemistry
(1 time)
CIS (1 time)
NAC (1 time)
2009 Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism.
82  AIDS by reverse transcriptase inhibitors, such as zidovudine
(1 time)
Pharmacology
(1 time)
--- 1997 A pharmacokinetic-pharmacodynamic model of chemotherapy of human immunodeficiency virus infection that relates development of drug resistance to treatment intensity.
83  AIDS clinical group protocol of zidovudine
(1 time)
Pharmacology
(1 time)
--- 2000 [New therapy reduces AIDS passed to fetuses and costs less].
84  AIDS in patients who started treatment with zidovudine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
ISS (1 time)
1998 Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study.
85  AIDS or severe HIV infection who have received long-term zidovudine
(1 time)
Public Health
(1 time)
AIDS (1 time)
HIV (1 time)
NHLs (1 time)
1991 Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy--United States.
86  AIDS patients who receive zidovudine
(1 time)
Medicine
(1 time)
8-oxodG (1 time)
mt (1 time)
1998 AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins.
87  AIDS resistant or non-resistant to zidovudine
(1 time)
Therapeutics
(1 time)
Tat (1 time)
1993 [Therapeutic potential of Ro 5-3335. New active benzodiazepine in vitro against HIV-1 viruses resistant or non-resistant to AZT].
88  AIDS took both zidovudine
(1 time)
Internal Medicine
(1 time)
--- 1994 Short-term, combined use of paracetamol and zidovudine does not alter the pharmacokinetics of either drug.
89  AIDS treated with long-term azidothymidine
(1 time)
Biochemistry
(1 time)
dG (1 time)
mtDNA (1 time)
1991 Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine.
90  AIDS-related complex treated with zidovudine
(1 time)
Biotechnology
(1 time)
HIV-1 (1 time)
1991 Quantitative estimation of human immunodeficiency virus type-1 provirus in CD4+ T lymphocytes using the polymerase chain reaction.
91  aimed at development and evaluation of zidovudin
(1 time)
Drug Delivery Systems
(1 time)
GNPs (1 time)
M-GNPs (1 time)
SEM (1 time)
2013 Development and characterization of gelatin based nanoparticles for targeted delivery of zidovudine.
92  Aiming to target 3'-azido-3'-deoxythymidine
(1 time)
Biochemistry
(1 time)
--- 2005 Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.
93  aims to study the effect of telomerase inhibitors zidovudine
(1 time)
Chemistry
(1 time)
--- 2014 Research for the influence of telomerase inhibitors on myeloma cell and therapy.
94  Akin to 3'-azido-2',3'-dideoxythymidine
(1 time)
Neoplasms
(1 time)
ddN (1 time)
HIV (1 time)
1987 Perspectives for the chemotherapy of AIDS.
95  albendazole, metronidazole, octreotide, and zidovudine
(1 time)
Laboratory Techniques and Procedures
(1 time)
AIDS (1 time)
1994 Intestinal microsporidiosis. Report of five cases.
96  alcohol intake, and zidovudine
(1 time)
Gastroenterology
(1 time)
AIDS (1 time)
HBeAb (1 time)
HBeAg (1 time)
1996 The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men.
97  all consecutive drug-naive HIV-infected individuals who started HAART with zidovudine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
AP (1 time)
ddI (1 time)
GGT (1 time)
2003 First-line therapy and mitochondrial damage: different nucleosides, different findings.
98  all four patients was with zidovudine
(1 time)
Communicable Diseases
(1 time)
HAART (1 time)
STI (1 time)
VL (1 time)
2010 Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds.
99  all the reference drugs zidovudine
(1 time)
Biochemistry
(1 time)
DAPYs (1 time)
DLV (1 time)
EFV (1 time)
2014 Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
100  all were found to be sensitive to zidovudine
(1 time)
Virology
(1 time)
HIV-1 (1 time)
TAMs (1 time)
WT (1 time)
2004 Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.